Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Bisaro Paul
Over the trailing 90 days, Bisaro Paul (Director at Keenova Therapeutics plc) bought $179K of stock across 3 companies, per 8 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 8 transactions · CIK 1237253
- Net activity
- +$179K ($179K bought · $0 sold)
By Company (Trailing 90 Days)
Transactions (8)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-15 | NONE | Buy | 4.4K | $0 | Grant, award or other acquisition |
| 2026-06-04 | MYGN | Buy | 59.7K | $0 | Grant, award or other acquisition |
| 2026-06-02 | NONE | Buy | 2.7K | $0 | Exercise or conversion of derivative security |
| 2026-06-02 | NONE | Sell | 619 | $0 | Payment of exercise price or tax liability by delivering securities |
| 2026-06-02 | NONE | Sell | 2.2K | $0 | Disposition to the issuer of issuer equity securities |
| 2026-06-02 | NONE | Sell | 2.7K | $0 | Exercise or conversion of derivative security |
| 2026-05-14 | MYGN | Buy | 7.5K | $28K | Open market or private purchase |
| 2026-05-13 | ZTS | Buy | 2.0K | $152K | Open market or private purchase |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Bisaro's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.